HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Narayana I Narasimhan Selected Research
Narayana I Narasimhan Research Topics
Disease
7
Neoplasms (Cancer)
01/2023 - 06/2011
7
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 06/2010
5
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 12/2011
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017 - 11/2012
4
Philadelphia Chromosome
01/2017 - 11/2012
2
Leukemia
01/2017 - 11/2012
1
Hypertension (High Blood Pressure)
12/2016
1
Neoplasm Metastasis (Metastasis)
12/2016
1
Lymphoma (Lymphomas)
01/2016
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2016
1
Endometrial Neoplasms (Endometrial Cancer)
05/2013
1
Pancreatitis
11/2012
1
Hematologic Neoplasms (Hematological Malignancy)
06/2011
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2011
Drug/Important Bio-Agent (IBA)
8
ponatinib
IBA
01/2017 - 06/2011
6
Tyrosine Kinase Inhibitors
IBA
01/2021 - 03/2012
5
Phosphotransferases (Kinase)
IBA
01/2016 - 06/2010
3
Anaplastic Lymphoma Kinase
IBA
12/2016 - 12/2011
2
mobocertinib
IBA
01/2023 - 01/2021
2
Crizotinib
IBA
12/2016 - 12/2011
2
brigatinib
IBA
12/2016 - 01/2016
2
Lipase (Acid Lipase)
FDA Link
12/2016 - 11/2012
2
ridaforolimus
IBA
05/2013 - 06/2011
1
ErbB Receptors (EGF Receptor)
IBA
01/2023
1
Dasatinib (BMS 354825)
FDA Link
01/2017
1
nilotinib
FDA Link
01/2017
1
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
01/2016
1
Enzymes
IBA
01/2016
1
Cytochrome P-450 CYP3A
IBA
01/2015
1
bcr-abl Fusion Proteins
IBA
09/2013
1
Drug Combinations
IBA
05/2013
1
Amylases
FDA Link
11/2012
1
Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)
IBA
03/2012
1
Biomarkers (Surrogate Marker)
IBA
06/2011
1
Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)
IBA
06/2011
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
06/2011
Therapy/Procedure
3
Therapeutics
01/2023 - 12/2016
1
Oral Administration
01/2023